{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:56:45Z","timestamp":1781053005808,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-47990-w","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:46:39Z","timestamp":1776483999000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extrapancreatic extension modifies chemotherapy benefit in resected pancreatic ductal adenocarcinoma: a population-based cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Shuai","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"47990_CR1","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop, T. F. et al. Pancreatic cancer. Lancet 405, 1182\u20131202 (2025).","journal-title":"Lancet"},{"key":"47990_CR2","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA. Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA. Cancer J. Clin."},{"key":"47990_CR3","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","volume":"379","author":"T Conroy","year":"2018","unstructured":"Conroy, T. et al. FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer. N. Engl. J. Med. 379, 2395\u20132406 (2018).","journal-title":"N. Engl. J. Med."},{"key":"47990_CR4","first-page":"1240","volume":"43","author":"DH Palmer","year":"2025","unstructured":"Palmer, D. H. et al. Pancreatic adenocarcinoma: long-term outcomes of adjuvant therapy in the ESPAC4 phase III trial. J. Clin. Oncol. 43, 1240\u20131253 (2025).","journal-title":"J. Clin. Oncol."},{"key":"47990_CR5","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.surg.2024.07.047","volume":"176","author":"Y Zou","year":"2024","unstructured":"Zou, Y. et al. Survival outcomes of adjuvant chemotherapy in patients with stage I pancreatic cancer stratified by pathologic risk. Surgery 176, 1466\u20131474 (2024).","journal-title":"Surgery"},{"key":"47990_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1093\/bjs\/znad146","volume":"110","author":"L Maggino","year":"2023","unstructured":"Maggino, L. et al. Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: Implications for adjuvant therapy. Br. J. Surg. 110, 973\u2013982 (2023).","journal-title":"Br. J. Surg."},{"key":"47990_CR7","unstructured":"AJCC Cancer Staging Manual. (Springer, New York, NY, 2017)."},{"key":"47990_CR8","doi-asserted-by":"crossref","unstructured":"Saka, B. et al. Pancreatic ductal adenocarcinoma is spread to the peripancreatic soft tissue in the majority of resected cases, rendering the AJCC T-stage protocol (7th edition) inapplicable and insignificant: a size-based staging system\u00a0(pT1: \u22642, pT2: >2-\u22644, pT3: >4 cm) is more valid and clinically relevant. Ann. Surg. Oncol. 23, 2010\u20132018 (2016).","DOI":"10.1245\/s10434-016-5093-7"},{"key":"47990_CR9","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1007\/s11605-023-05850-2","volume":"27","author":"M Lee","year":"2023","unstructured":"Lee, M. et al. Reconsidering the absence of extrapancreatic extension in T staging for pancreatic adenocarcinoma in the AJCC (8th ed) staging manual using the National Cancer Database. J. Gastrointest. Surg. 27, 2484\u20132492 (2023).","journal-title":"J. Gastrointest. Surg."},{"key":"47990_CR10","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00330-021-08180-6","volume":"32","author":"F Toshima","year":"2022","unstructured":"Toshima, F. et al. CT-diagnosed extra-pancreatic extension of pancreatic ductal adenocarcinoma is a more reliable prognostic factor for survival than pathology-diagnosed extension. Eur. Radiol. 32, 22\u201333 (2022).","journal-title":"Eur. Radiol."},{"key":"47990_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.hpb.2023.06.015","volume":"25","author":"A Hayasaki","year":"2023","unstructured":"Hayasaki, A. et al. Extrapancreatic extension is a better adverse prognostic factor than tumor size in patients with localized pancreatic ductal adenocarcinoma treated with chemoradiotherapy - Comparison of T category between the American Joint Committee on Cancer and Japan Pancreas Society. HPB 25, 1268\u20131277 (2023).","journal-title":"HPB"},{"key":"47990_CR12","doi-asserted-by":"publisher","first-page":"6752","DOI":"10.3748\/wjg.v25.i46.6752","volume":"25","author":"H-Y Chen","year":"2019","unstructured":"Chen, H.-Y., Wang, X., Zhang, H., Liu, X.-B. & Tan, C.-L. Mesenterico-portal vein invasion should be an important factor in TNM staging for pancreatic ductal adenocarcinoma: Proposed modification of the 8th edition of the American Joint Committee on Cancer staging system. World J. Gastroenterol. 25, 6752\u20136766 (2019).","journal-title":"World J. Gastroenterol."},{"key":"47990_CR13","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1097\/JS9.0000000000002288","volume":"111","author":"Z Chen","year":"2025","unstructured":"Chen, Z. et al. Utilizing explainable machine learning for progression-free survival prediction in high-grade serous ovarian cancer: Insights from a prospective cohort study. Int. J. Surg. 111, 3224\u20133234 (2025).","journal-title":"Int. J. Surg."},{"key":"47990_CR14","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1093\/ije\/dyw145","volume":"45","author":"S Dietrich","year":"2016","unstructured":"Dietrich, S. et al. Random survival forest in practice: a method for modelling complex metabolomics data in time to event analysis. Int. J. Epidemiol. 45, 1406\u20131420 (2016).","journal-title":"Int. J. Epidemiol."},{"key":"47990_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"47990_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1093\/annonc\/mdv500","volume":"27","author":"KS Tewari","year":"2016","unstructured":"Tewari, K. S., Java, J. J., Eskander, R. N., Monk, B. J. & Burger, R. A. Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology\/Gynecologic Oncology Group study. Ann. Oncol. 27, 114\u2013121 (2016).","journal-title":"Ann. Oncol."},{"key":"47990_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/oxfordjournals.aje.a008670","volume":"143","author":"FJ Nieto","year":"1996","unstructured":"Nieto, F. J. & Coresh, J. Adjusting survival curves for confounders: A review and a new method. Am. J. Epidemiol. 143, 1059\u20131068 (1996).","journal-title":"Am. J. Epidemiol."},{"key":"47990_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43064-x","volume":"14","author":"C Ding","year":"2023","unstructured":"Ding, C. et al. Binge-pattern alcohol consumption and genetic risk as determinants of alcohol-related liver disease. Nat. Commun. 14, 8041 (2023).","journal-title":"Nat. Commun."},{"key":"47990_CR19","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1093\/ije\/dyr218","volume":"41","author":"MJ Knol","year":"2012","unstructured":"Knol, M. J. & VanderWeele, T. J. Recommendations for presenting analyses of effect modification and interaction. Int. J. Epidemiol. 41, 514\u2013520 (2012).","journal-title":"Int. J. Epidemiol."},{"key":"47990_CR20","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.6004\/jnccn.2019.7322","volume":"17","author":"NN Sanford","year":"2019","unstructured":"Sanford, N. N. et al. Sociodemographic disparities in the receipt of adjuvant chemotherapy among patients with resected stage I-III pancreatic adenocarcinoma. J. Natl. Compr. Cancer Netw. JNCCN 17, 1292\u20131300 (2019).","journal-title":"J. Natl. Compr. Cancer Netw. JNCCN"},{"key":"47990_CR21","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2018.3617","volume":"153","author":"S van Roessel","year":"2018","unstructured":"van Roessel, S. et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer. JAMA Surg. 153, e183617 (2018).","journal-title":"JAMA Surg."},{"key":"47990_CR22","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/jhbp.12056","volume":"31","author":"M Ishida","year":"2024","unstructured":"Ishida, M. et al. Japanese classification of pancreatic carcinoma by the Japan Pancreas Society: Eighth edition. J. Hepato-Biliary-Pancreat. Sci. 31, 755\u2013768 (2024).","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"47990_CR23","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1158\/1078-0432.CCR-20-0418","volume":"26","author":"W Park","year":"2020","unstructured":"Park, W. et al. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. Clin. Cancer Res. 26, 3239\u20133247 (2020).","journal-title":"Clin. Cancer Res."},{"key":"47990_CR24","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1053\/j.gastro.2021.01.220","volume":"160","author":"T Golan","year":"2021","unstructured":"Golan, T. et al. Genomic Features and Classification of Homologous Recombination Deficient Pancreatic Ductal Adenocarcinoma. Gastroenterology 160, 2119-2132.e9 (2021).","journal-title":"Gastroenterology"},{"key":"47990_CR25","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1053\/j.gastro.2020.09.043","volume":"160","author":"SB Dreyer","year":"2021","unstructured":"Dreyer, S. B. et al. Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology 160, 362-377.e13 (2021).","journal-title":"Gastroenterology"},{"key":"47990_CR26","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cell.2019.05.012","volume":"178","author":"M Ligorio","year":"2019","unstructured":"Ligorio, M. et al. Stromal microenvironment shapes the intratumoral architecture of pancreatic cancer. Cell 178, 160-175.e27 (2019).","journal-title":"Cell"},{"key":"47990_CR27","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43018-020-00121-4","volume":"1","author":"NG Steele","year":"2020","unstructured":"Steele, N. G. et al. Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer. Nat. Cancer 1, 1097\u20131112 (2020).","journal-title":"Nat. Cancer"},{"key":"47990_CR28","volume":"5","author":"AN Hosein","year":"2019","unstructured":"Hosein, A. N. et al. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution. JCI Insight 5, e129212, 129212 (2019).","journal-title":"JCI Insight"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47990-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47990-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:58:29Z","timestamp":1781049509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-47990-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["47990"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-47990-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"26 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Since the SEER database is publicly available, this study was exempt from review by the Ethics Committee of the authors\u2019 hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was waived due to the use of de-identified data from the SEER public database.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"17973"}}